FDA Adverse Event Death Summary report: N

WALLSTENT ILIAC ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM

MDR report key: 1744728 · Received July 2, 2010

Report

Report Number
2134265-2009-05183
Event Type
Death
Date Received
July 2, 2010
Date of Event
May 30, 2005
Report Date
May 30, 2005
Manufacturer
BOSTON SCIENTIFIC IRELAND LTD.
Product Code
MAF
PMA / PMN Number
P940019
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
HU
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

THE DEVICE WILL NOT BE RETURNED FOR EVALUATION. THEREFORE A FAILURE ANALYSIS OF THE COMPLAINT DEVICE COULD NOT BE COMPLETED. THE BATCH NUMBER IS UNKNOWN. THEREFORE A REVIEW OF THE MANUFACTURING DOCUMENTATION COULD NOT BE PERFORMED. THE MOST PROBABLE ROOT CAUSE IS ANTICIPATED PROCEDURAL COMPLICATION AS THIS EVENT IS A KNOWN PHYSIOLOGICAL EFFECT OF THE PROCEDURE AND IS NOTED IN THE DIRECTION FOR USE (DFU). (B)(4), DEVICE NOT RETURNED FOR ANALYSIS.

Description of Event or Problem · 1

(B)(4). IT WAS REPORTED THAT POST A PERCUTANEOUS TRANSLUMINAL ANGIOPLASTY (PTA) THE PATIENT DIED. THE TARGET LESION LOCATION WAS IN THE RIGHT EXTERNAL ILIAC. THE LESION CHARACTERISTICS WERE AN AVERAGE LESION WITH AN INTRALUMINAL DIAMETER THAT WAS 2 MM AND THE TOTAL LESION LENGTH WAS 60 MM. THE WALLSTENT HAD A DIAMETER OF 7MM AND A LENGTH OF 55MM WAS IMPLANTED. THE CLINICAL AND RADIOLOGICAL ASSESSMENT WAS TECHNICALLY SUCCESSFUL AND THERE WERE NO PROCEDURE RELATED COMPLICATIONS. THE CONTROL PERFORMANCE AT DISCHARGE SHOWED THERE WAS EVIDENCE OF IMPROVEMENT IN THE LUMINAL DIAMETER TO LESS THAN OR EQUAL TO 30% RESIDUAL STENOSIS. THERE WAS HEMODYNAMIC SUCCESS AND CLINICAL SUCCESS. AT THE ONE MONTH FOLLOW UP IT WAS DOCUMENTED THAT THE PATIENT HAD DIED IN (B)(6) OF 2005, 24 DAYS AFTER THE INDEX PROCEDURE. NO ADDITIONAL INFORMATION WAS PROVIDED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 WALLSTENT ILIAC ENDOPROSTHESIS WITH UNISTEP PLUS DELIVERY SYSTEM STENT, CORONARY MAF BOSTON SCIENTIFIC IRELAND LTD. 71-212

Patients

Seq Age Sex Outcome Treatment
1 77 YR Death| H